Vera Therapeutics Stock (NASDAQ: VERA)
|Day Range19.95 - 22.79||52 Wk Range12.29 - 29.2||Open / Close20.59 / 22.19||Float / Outstanding12.1M / 27.1M|
|Vol / Avg.168.2K / 85.4K||Mkt Cap602.3M||P/E-||50d Avg. Price19.85|
|Div / Yield-||Payout Ratio-||Total Float12.1M||EPS-0.55|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vera Therapeutics (NASDAQ: VERA) through any online brokerage.
The latest price target for Vera Therapeutics (NASDAQ: VERA) was reported by HC Wainwright & Co. on Monday, August 22, 2022. The analyst firm set a price target for 36.00 expecting VERA to rise to within 12 months (a possible 62.24% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Vera Therapeutics (NASDAQ: VERA) is $22.19 last updated October 4, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.
Vera Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Vera Therapeutics.
Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.